Research Review: Cholinergic mechanisms, early brain development, and risk for schizophrenia
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
The onset of diagnostic symptomology for neuropsychiatric diseases is often the end result of a decades‐long process of aberrant brain development. Identification of novel treatment strategies aimed at normalizing early brain development and preventing mental illness should be a major therapeutic goal. However, there are few models for how this goal might be achieved. This review uses the development of a psychophysiological correlate of attentional deficits in schizophrenia to propose a developmental model with translational primary prevention implications. Review of genetic and neurobiological studies suggests that an early interaction between α7 nicotinic receptor density and choline availability may contribute to the development of schizophrenia‐associated attentional deficits. Therapeutic implications, including perinatal dietary choline supplementation, are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033430 · Cited by 2,999
Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS
Green, M. F., Kern, R. S., & Heaton, R. K. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.09.009 · Cited by 1,422
Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort
JONES, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90569-x · Cited by 1,353
Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group
Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S. M., McFarlane, C. A., Hallgren, M., & McGorry, P. D. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00167-6 · Cited by 1,136
Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia
Saykin, A. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020048005 · Cited by 1,086
Choline: Critical Role During Fetal Development and Dietary Requirements in Adults
Zeisel, S. H. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111156 · Cited by 741 · cited 1×
“um levels (Zeisel, 2006).”
The nurse–family partnership: An evidence‐based preventive intervention
Olds, D. L. (2006) · Infant Mental Health Journal · doi:10.1002/imhj.20077 · Cited by 729
Stability and Course of Neuropsychological Deficits in Schizophrenia
Heaton, R. K., Gladsjo, J. A., Palmer, B. W., Kuck, J., Marcotte, T. D., & Jeste, D. V. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.1.24 · Cited by 618 · cited 1×
“Schizophreniaassociated cognitive impairments are stable across the course of the disease (Rund, 1998; Heaton et al., 2001; Censits, Ragland, Gur, & Gur, 1997; Hill, Schuepbach, Herbener, Keshevan, & Sweeney, 2004) and present at the same level of impairment at first episode (Bilder et al.”
Behavioral and Intellectual Markers for Schizophrenia in Apparently Healthy Male Adolescents
Davidson, M., Reichenberg, A., Rabinowitz, J., Weiser, M., Kaplan, Z., & Mark, M. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1328 · Cited by 582
Meta-analysis of the P300 and P50 waveforms in schizophrenia
BRAMON, E. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.01.004 · Cited by 569
Cited by
The origin of NMDA receptor hypofunction in schizophrenia
Nakazawa, K., & Sapkota, K. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107426 · Cited by 275
Perinatal Choline Effects on Neonatal Pathophysiology Related to Later Schizophrenia Risk
Ross, R. G., Hunter, S. K., McCarthy, L., Beuler, J., Hutchison, A. K., Wagner, B. D., Leonard, S., Stevens, K. E., & Freedman, R. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12070940 · Cited by 165
Self-citationBell, K. A., Shim, H., Chen, C.-K., & McQuiston, A. R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.024 · Cited by 74
“Due to their potential roles in schizophrenia and AD (Guan et al., 2000; Massoud and Gauthier, 2010; Ross et al., 2010; Taly et al., 2009), there has been more attention given to functional studies of α7 nicotinic receptors than any other nicotinic subunit found in the hippocampus (Alkondon et al.,…”
BackgroundNew Targets for Prevention of Schizophrenia: Is It Time for Interventions in the Premorbid Phase?
Seidman, L. J., & Nordentoft, M. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv050 · Cited by 65
Hunter, S. K., Kisley, M. A., McCarthy, L., Freedman, R., & Ross, R. G. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq036 · Cited by 38
Metadata
- Authors
- Ross, R. G., Stevens, K. E., Proctor, W. R., Leonard, S., Kisley, M. A., Hunter, S. K., Freedman, R., & Adams, C. E.
- Venue
- Journal of Child Psychology and Psychiatry
- Publisher
- Wiley
- Published
- 2010-04
- Volume
- 51
- Issue
- 5
- Pages
- 535-549
- ISSN
- 0021-9630 (ISSN-L)
- 1469-7610
- OpenAlex
- W1534454654
- Cited by
- 56
- References
- 12
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Research Review: Cholinergic mechanisms, early brain development, and risk for schizophrenia. https://app.cochat.ai/papers/10.1111/j.1469-7610.2009.02187.x
- The paper
- Ross, R. G., Stevens, K. E., Proctor, W. R., Leonard, S., Kisley, M. A., Hunter, S. K., Freedman, R., & Adams, C. E. (2010). Research Review: Cholinergic mechanisms, early brain development, and risk for schizophrenia. Journal of Child Psychology and Psychiatry. https://doi.org/10.1111/j.1469-7610.2009.02187.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.